World's Best Scientists 2026 revealed!
Toshiaki A. Furukawa

Toshiaki A. Furukawa

Award Badge
Psychology
Japan
2026

D-Index & Metrics

Psychology

D-Index
51
Citations
11929
World Ranking
5177
National Ranking
8

Research.com Recognitions

  • 2026 - Research.com Psychology in Japan Leader Award
  • 2025 - Research.com Psychology in Japan Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Psychiatry
  • Major depressive disorder

Toshiaki A. Furukawa spends much of his time researching Psychiatry, Depression, Internal medicine, Randomized controlled trial and Quality of life. His Psychiatry research focuses on Alexithymia in particular. His study in Depression is interdisciplinary in nature, drawing from both Mental health, Physical therapy and Alcohol abuse.

His Internal medicine research integrates issues from Venlafaxine, Relapse prevention, CINAHL and Sertraline. His research in Sertraline intersects with topics in Escitalopram, Tolerability, Systematic review, Duloxetine and Mirtazapine. His work deals with themes such as Odds ratio, Clinical trial, Absolute risk reduction, Meta-analysis and Placebo, which intersect with Randomized controlled trial.

His most cited work include:

  • Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis (1246 citations)
  • Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review (658 citations)
  • Cross-cultural validation of the Beck Depression Inventory-II in Japan. (290 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Psychiatry, Depression, Clinical psychology, Internal medicine and Psychometrics. His research links Randomized controlled trial with Psychiatry. His research integrates issues of Cancer, Psychosocial, Anxiety, Hemodialysis and Pediatrics in his study of Depression.

His Clinical psychology research also works with subjects such as

  • Cronbach's alpha that intertwine with fields like Construct validity,
  • Cognition that connect with fields like Degenerative disease, Cognitive psychology and Dementia. His Internal medicine study combines topics in areas such as Antidepressant, Sertraline and Venlafaxine. His Psychometrics research includes themes of Item response theory, Center for Epidemiologic Studies Depression Scale, Major depressive episode and Rating scale.

He most often published in these fields:

  • Psychiatry (52.43%)
  • Depression (29.13%)
  • Clinical psychology (24.27%)

What were the highlights of his more recent work (between 2008-2020)?

  • Psychiatry (52.43%)
  • Clinical psychology (24.27%)
  • Depression (29.13%)

In recent papers he was focusing on the following fields of study:

Psychiatry, Clinical psychology, Depression, Internal medicine and Mental health are his primary areas of study. His Psychiatry research incorporates elements of Odds ratio and Risk factor. His work on Psychometrics as part of general Clinical psychology study is frequently linked to Human sexuality, bridging the gap between disciplines.

Toshiaki A. Furukawa combines subjects such as Cancer, Physical therapy, Severity of illness and Rheumatoid arthritis with his study of Depression. The concepts of his Internal medicine study are interwoven with issues in Mirtazapine and Oncology. Toshiaki A. Furukawa has researched Mental health in several fields, including Alternative medicine, Public health and Comorbidity.

Between 2008 and 2020, his most popular works were:

  • Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis (1246 citations)
  • Depression, inflammation, and pain in patients with rheumatoid arthritis. (143 citations)
  • Systematic review and meta-analysis of cannabis treatment for chronic pain. (140 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Psychiatry
  • Major depressive disorder

Toshiaki A. Furukawa mostly deals with Psychiatry, Quality of life, Internal medicine, Hospital Anxiety and Depression Scale and Physical therapy. His study in Psychiatry is interdisciplinary in nature, drawing from both Odds ratio, Randomized controlled trial, Meta-analysis, Placebo and Disease. His Internal medicine research integrates issues from Venlafaxine, Escitalopram, Duloxetine and Citalopram.

His research investigates the link between Hospital Anxiety and Depression Scale and topics such as Psychological intervention that cross with problems in Clinical psychology. His Physical therapy research is multidisciplinary, incorporating perspectives in Psychosocial, Cross-sectional study, Depression and Anxiety. Toshiaki A. Furukawa is studying Beck Depression Inventory, which is a component of Depression.

Best Publications

  • Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

    Andrea Cipriani;Andrea Cipriani;Toshiaki A Furukawa;Georgia Salanti;John R Geddes

  • Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

    John R Geddes;Stuart M Carney;Christina Davies;Toshiaki A Furukawa

  • Cross-cultural validation of the Beck Depression Inventory-II in Japan

    Masayo Kojima;Toshiaki A Furukawa;Hidekatsu Takahashi;Makoto Kawai

  • Twelve‐month prevalence, severity, and treatment of common mental disorders in communities in Japan: preliminary finding from the World Mental Health Japan Survey 2002–2003

    Norito Kawakami;Tadashi Takeshima;Yutaka Ono;Hidenori Uda

  • Systematic review and meta-analysis of cannabis treatment for chronic pain.

    Eva Martín-Sánchez;Toshiaki A. Furukawa;Julian Taylor;Jose Luis R. Martin

  • Can we individualize the ‘number needed to treat’? An empirical study of summary effect measures in meta-analyses

    Toshiaki A Furukawa;Gordon H Guyatt;Lauren E Griffith

  • Depression, inflammation, and pain in patients with rheumatoid arthritis.

    Masayo Kojima;Toshihisa Kojima;Sadao Suzuki;Takeshi Oguchi

  • Efficacy of cognitive bias modification interventions in anxiety and depressive disorders: a systematic review and network meta-analysis.

    Liviu A Fodor;Raluca Georgescu;Pim Cuijpers;Ştefan Szamoskozi

  • Depression as a potential causal factor in subsequent miscarriage in recurrent spontaneous aborters

    Mayumi Sugiura-Ogasawara;Toshiaki A. Furukawa;Yumi Nakano;Shiro Hori

  • Patient's perceived need and psychological distress and/or quality of life in ambulatory breast cancer patients in Japan

    Tatsuo Akechi;Toru Okuyama;Chiharu Endo;Ryuichi Sagawa

  • Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence

    Norman Sartorius;Thomas C. Baghai;David S. Baldwin;Barbara Barrett

  • Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials

    Corrado Barbui;Toshiaki A. Furukawa;Andrea Cipriani

  • Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials.

    Jose Luis R. Martin;Maria Sainz-Pardo;Toshiaki A. Furukawa;Eva Martin-Sanchez

  • Psychosocial factors, disease status, and quality of life in patients with rheumatoid arthritis

    Masayo Kojima;Toshihisa Kojima;Naoki Ishiguro;Takeshi Oguchi

  • Alexithymia, Depression and Social Support among Japanese Workers

    Masayo Kojima;Yoshihiro Senda;Teruo Nagaya;Shinkan Tokudome

  • Neuropsychiatric symptoms predict change in quality of life of Alzheimer disease patients: a two-year follow-up study.

    Hiroshi Tatsumi;Shutaro Nakaaki;Katsuyoshi Torii;Yoshihiro Shinagawa

  • Time to recovery of an inception cohort with hitherto untreated unipolar major depressive episodes

    Toshiaki A. Furukawa;Toshinori Kitamura;Kiyohisa Takahashi

  • Early parental separation experiences among patients with bipolar disorder and major depression: a case-control study.

    T.A Furukawa;A Ogura;T Hirai;S Fujihara

  • The differential impact of executive attention dysfunction on episodic memory in obsessive-compulsive disorder patients with checking symptoms vs. those with washing symptoms.

    Ichiro M. Omori;Yoshie Murata;Tomoaki Yamanishi;Shutaro Nakaaki

  • Are all antidepressants really the same? The case of fluoxetine: a systematic review.

    Andrea Cipriani;Corrado Barbui;Paolo Brambilla;Toshiaki A. Furukawa

  • Course of psychological distress and its predictors in advanced non-small cell lung cancer patients.

    Tatsuo Akechi;Toru Okuyama;Nobuya Akizuki;Hideki Azuma

Frequent Co-Authors

Toshinori Kitamura
Toshinori Kitamura Kitamura Institute of Mental Health Tokyo
Masaru Mimura
Masaru Mimura Keio University
Yutaka Ono
Yutaka Ono Keio University
Hitoshi Okamura
Hitoshi Okamura Hiroshima University
Tetsuya Iidaka
Tetsuya Iidaka Nagoya University
Elena Tomba
Elena Tomba University of Bologna
Richard Balon
Richard Balon Wayne State University
Miia Kivipelto
Miia Kivipelto University of Eastern Finland
Karina W. Davidson
Karina W. Davidson Feinstein Institute for Medical Research
Dorly J. H. Deeg
Dorly J. H. Deeg University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in psychology can open doors to a range of rewarding careers, including various roles in social work. As a licensed social worker, you will help individuals, families, and communities improve their well-being—often building on a psychology background. However, educational requirements to become a social worker can differ significantly across states.

For example, those interested in becoming a social worker should carefully review the social worker degree requirements in Kansas. Requirements can include specific accredited degrees and supervised fieldwork. Similarly, learning about the social worker education requirements in Kentucky helps prospective students understand regional licensing standards.

Other states, such as Louisiana and Maine, also have unique standards. Students should research the degree needed to be a social worker in Louisiana and the degree needed to be a social worker in Maine before choosing an educational program. Comparing these options helps future professionals choose the best pathway to meet their career goals, either on campus or through accredited online degrees.

Best Scientists Citing Toshiaki A. Furukawa

Trending Scientists

Recently Published Articles